Concepedia

Sherry A. Goodner

SA

10

Publications

457

Citations

10

H-Index

1994

Active since

Affiliations

Washington University in St. Louis(Current)

Alvin J. Siteman Cancer Center

Jewish Hospital

National Cancer Institute

National Institutes of Health

Sherry A. Goodner is an author at Washington University in St. Louis specializing in oncology, cancer therapeutics, and cancer research.

Top concepts

Publications per year

1994–2013

10

Publications

10

A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing

Paula M. Fracasso, Howard A. Burris, Matthew A. Arquette et al. · Clinical Cancer Research · 2007 · 148 citations

Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies

Paula M. Fracasso, Lori J. Goldstein, Dinesh P. de Alwis et al. · Clinical Cancer Research · 2004 · 70 citations

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies

Paula M. Fracasso, Kerry J. Williams, Ronald C. Chen et al. · Cancer Chemotherapy and Pharmacology · 2010 · 68 citations · Full text

Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies

Paula M. Fracasso, Joel Picus, Jonathan D. Wildi et al. · Cancer Chemotherapy and Pharmacology · 2008 · 49 citations

, , +11

Safe handling practices of cytotoxic drugs: the results of a chapter survey.

Suzanne M. Mahon, D S Casperson, Susan Yackzan et al. · PubMed · 1994 · 30 citations

Rows per page

1–5 of 10